SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Clever Leaves Holdings Inc. CLVR OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Clever Leaves Holdings Inc. (CLVR) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 34/100, indicating a weak investment profile with 1 out of 7 criteria passed.

Financials: revenue is $17M, +13.5%/yr average growth. Net income is $18M (loss), growing at +6%/yr. Net profit margin is -102.8% (negative). Gross margin is 37.6% (-23.6 pp trend).

Balance sheet: total debt is $2M against $24M equity (Debt-to-Equity (D/E) ratio 0.09, conservative). Current ratio is 2.4 (strong liquidity). Debt-to-assets is 6.7%. Total assets: $31M.

Analyst outlook: 1 / 2 analysts rate CLVR as buy (50%) — moderate consensus.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 73/100 (Pass), Past 0/100 (Fail), Health 67/100 (Partial), Moat 21/100 (Fail), Future 40/100 (Partial), Income 10/100 (Fail).

CLVR SharesGrow Score Overview

42/100

SharesGrow Score

Mixed signals — some strengths

View full scorecard →

VALUE 0/100

Valuation — P/E, PEG, Forward PEG

GROWTH 73/100

Financials — average growth

PAST 0/100

strong — trend

HEALTH 67/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 21/100

Gross margin is + market cap

FUTURE 40/100

Analyst outlook — as buy

INCOME 10/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — CLVR

No analyst coverage available for this stock.

CLVR: +13.5%/yr revenue is, +6%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

No analyst coverage available for this stock.

Balance sheet CLVR: Debt-to-Equity (D/E) ratio 0.09 (conservative), Current ratio is 2.4 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

CLVR: Gross margin is 37.6% (-23.6 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 21/100. ≥ 70 = Pass.

View details →

Analyst outlook: 1 / 2 analysts rate CLVR as buy (50%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.

View details →

CLVR: Net profit margin is -102.8%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range0.0001-0.50005

Volume25.27K

Avg Volume (30D)812

Market Cap$1.05K

Beta (1Y)4.48

Share Statistics

EPS (TTM)-11.42

Shares Outstanding$1.57M

IPO Date2020-12-18

Employees296

CEOAndres Fajardo

Financial Highlights & Ratios

Revenue (TTM)$17.42M

Gross Profit$6.56M

EBITDA$-16.84M

Net Income$-17.9M

Operating Income$-15.59M

Total Cash$6.83M

Total Debt$2.09M

Net Debt$-4.74M

Total Assets$31.24M

Price / Earnings (P/E)-0

Price / Sales (P/S)0

Analyst Forecast

Rating ConsensusBuy

Analysts Covering2

Buy 50% Hold 50% Sell 0%

Company Info

CountryUS

ExchangeOther OTC

CurrencyUSD

ISINCA1867602031

Price Chart

CLVR

Clever Leaves Holdings Inc. ↗ · Other OTC

Healthcare • Drug Manufacturers - Specialty & Generic

0.00 52WK RANGE 0.50

People Also View

Flora Growth Corp.

MedAvail Holdings, Inc.

AgriFORCE Growing Systems Ltd.

Greenlane Holdings, Inc.

Eli Lilly and Company

Johnson & Johnson

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message